China Listed Drug Analysis Report! 13 medical insurance drugs, 8 exclusive varieties, 12 exclusive varieties of the same product rules...

Point of view:may the total number of new approvals of the Drug Enforcement Administration was 51may added 8 exclusive varieties of approvalmay added 42 new domestic drug approvals and 9 import approvalsAccording to the latest statistics of the enterprise version of the data, 51 new approvals were added in May 2020Figure 1 New approval slots from January to May 2020
may 42 new approvals are domestic drugs and 9 are imported drugsBelow and see the details of the new approvalsFirst, the drug type
In May, the Drug Administration added 29 new approvals for chemical drugs, 1 approval for biological products and 21 chinese medicine approvalsFigure II January-May 2020 Drug Administration of each drug type, dosage formMay FDA approved the top three dosage forms for pills 21 approvals, tablets 12 approvals (specific new dosage form see figure below)Figure III In May 2020, the drug administration's various dosage formsthree, the medical insurance categorymay of the new approval of 13 of which belong to the 2019 new version of the national health insurance catalog of Class A drugs, 20 approvals belong to the 2019 new version of the National Health Insurance Directory of Class B drugsFigure 4 The number of approvals in each medical insurance category of the Drug Enforcement Administration in January-May 2020 four, and the number of approvals in each province
in May, the registered address of the new batch of enterprises ranked first in Guangxi, with 21 Figure V In May 2020, the provinces have the number of approvals
5, the exclusive situation the same varieties have 8 approvals, details are shown in table 1 Figure VI May 2020 with the same variety of exclusive categories quantity Table 1 May 2020 with the same variety of exclusive drug data as of June 2, 2020
the same product rules exclusive 12 approvals (the same product rules exclusive contain the same variety exclusive), details are shown in Table II Figure 7 The number of exclusive categories of the same product rules for May 2020
Table II The data for the exclusive drug of the same product regulations in May 2020 ended on June 2, 2020